Accrol Group Holdings plc Notice of Half Year Results

Accrol Group Holdings plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Accrol Group Holdings plc (LON:ACRL), the AIM listed independent tissue converter and supplier to some of the UK’s largest retailers, will announce its Half Year Results for the six months ended 30 October 2017 on Monday, 22 January 2018, including an update on the Company’s progress since the £18m fundraising announced on 20 November 2017.

The Company will hold an analyst briefing at 9.30am on the day of its results. Analysts interested in attending the briefing should contact Belvedere Communications for details.

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues as well as other tissue products to the UK’s largest retailers.

It operates from three sites:

· a 350,000 sq ft manufacturing, storage and distribution facility in Blackburn;

· a 70,000 sq ft facial tissue plant, also in Blackburn; and

· a 168,000 sq ft manufacturing, storage and distribution facility in Leyland.

In addition, the business has a 368,000 sq ft storage and distribution facility in Skelmersdale, Lancashire.

The company manufactures approximately 18 million units per week, supplying customers with both Accrol branded and “private label” products.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Accrol Group Holdings plc (LON:ACRL) has announced the publication of a shareholder circular detailing terms of the Scheme. Learn more here.
Discover the latest results and overview of Accrol Group Holdings, the UK's top independent tissue converter, led by CEO Gareth Jenkins and CFO Chris Welsh.
In this interview, Gervais Williams, co-fund manager of Miton UK MicroCap Trust, discusses navigating the economic landscape and standout companies in 2024. Find out more here. #investment #microcap
Accrol Group Holdings plc has reported strong H1 FY24 results, with impressive growth in adjusted EBITDA and adjusted PBT. The company remains on track to meet expectations and has seen gains in market share. Furthermore, the private label segment of the UK tissue market continues to increase, and the sales of biodegradable wet wipes have been exceptionally strong. Accrol's outlook remains positive with expected further volume growth.
Accrol Group Holdings plc has reported strong performance in H1 FY24, with branded volumes rising by 45% and margins returning to pre-pandemic levels. The group is on track to deliver FY24 results in line with expectations and expects to outperform previous expectations for FY25.

Search

Search